Literature DB >> 25330715

The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes.

Amel Karaa1, Amy Goldstein.   

Abstract

Primary mitochondrial diseases refer to a group of heterogeneous and complex genetic disorders affecting 1:5000 people. The true prevalence is anticipated to be even higher because of the complexity of achieving a diagnosis in many patients who present with multisystemic complaints ranging from infancy to adulthood. Diabetes is a prominent feature of several of these disorders which might be overlooked by the endocrinologist. We here review mitochondrial disorders and describe the phenotypic and pathogenetic differences between mitochondrial diabetes mellitus (mDM) and other more common forms of diabetes mellitus.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Kearns Sayre syndrome; MELAS; diabetes; mitochondria; mtDNA

Mesh:

Substances:

Year:  2014        PMID: 25330715     DOI: 10.1111/pedi.12223

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  31 in total

Review 1.  Role of mitochondria in pathogenesis of type 2 diabetes mellitus.

Authors:  Pankaj Prasun
Journal:  J Diabetes Metab Disord       Date:  2020-11-02

Review 2.  The Role of Mitochondria in Diabetic Kidney Disease.

Authors:  Stein Hallan; Kumar Sharma
Journal:  Curr Diab Rep       Date:  2016-07       Impact factor: 4.810

Review 3.  Mitochondrial disease and endocrine dysfunction.

Authors:  Jasmine Chow; Joyeeta Rahman; John C Achermann; Mehul T Dattani; Shamima Rahman
Journal:  Nat Rev Endocrinol       Date:  2016-10-07       Impact factor: 43.330

Review 4.  Overview of Atypical Diabetes.

Authors:  Jaclyn Tamaroff; Marissa Kilberg; Sara E Pinney; Shana McCormack
Journal:  Endocrinol Metab Clin North Am       Date:  2020-10-14       Impact factor: 4.741

5.  Low prevalence of patients with mitochondrial disease in the German/Austrian DPV diabetes registry.

Authors:  Christina Reinauer; Thomas Meissner; Michael Roden; Angelika Thon; Paul-Martin Holterhus; Holger Haberland; Elisabeth Binder; Wolfgang Marg; Esther Bollow; Reinhard Holl
Journal:  Eur J Pediatr       Date:  2015-12-15       Impact factor: 3.183

Review 6.  Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

Authors:  Sumit Parikh; Amy Goldstein; Amel Karaa; Mary Kay Koenig; Irina Anselm; Catherine Brunel-Guitton; John Christodoulou; Bruce H Cohen; David Dimmock; Gregory M Enns; Marni J Falk; Annette Feigenbaum; Richard E Frye; Jaya Ganesh; David Griesemer; Richard Haas; Rita Horvath; Mark Korson; Michael C Kruer; Michelangelo Mancuso; Shana McCormack; Marie Josee Raboisson; Tyler Reimschisel; Ramona Salvarinova; Russell P Saneto; Fernando Scaglia; John Shoffner; Peter W Stacpoole; Carolyn M Sue; Mark Tarnopolsky; Clara Van Karnebeek; Lynne A Wolfe; Zarazuela Zolkipli Cunningham; Shamima Rahman; Patrick F Chinnery
Journal:  Genet Med       Date:  2017-07-27       Impact factor: 8.822

7.  Mitochondrial disease patients with novel ND4 12058A > C and ND1 m.3911A > G variations: implications for a role in the phenotype following a bioinformatic investigation.

Authors:  Emna Mkaouar-Rebai; Marwa Ammar; Lamia Sfaihi; Olfa Alila-Fersi; Marwa Maalej; Rahma Felhi; Mongia Hachicha; Faiza Fakhfakh
Journal:  Mol Biol Rep       Date:  2021-06-05       Impact factor: 2.316

8.  Mitochondrial Disease: Advances in clinical diagnosis, management, therapeutic development, and preventative strategies.

Authors:  Colleen C Muraresku; Elizabeth M McCormick; Marni J Falk
Journal:  Curr Genet Med Rep       Date:  2018-05-02

9.  Potential Pathogenicity of Candida Species Isolated from Oral Cavity of Patients with Diabetes Mellitus.

Authors:  Hasti Nouraei; Mehdi Ghaderian Jahromi; Leila Razeghian Jahromi; Kamiar Zomorodian; Keyvan Pakshir
Journal:  Biomed Res Int       Date:  2021-05-26       Impact factor: 3.411

10.  Management of mitochondrial diabetes in the era of novel therapies.

Authors:  Roseanne O Yeung; Mohammad Al Jundi; Sriram Gubbi; Maria E Bompu; Sandra Sirrs; Mark Tarnopolsky; Fady Hannah-Shmouni
Journal:  J Diabetes Complications       Date:  2020-04-13       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.